Approval · Notice of Compliance 13512 · 2012
MINT-FINASTERIDE: Notice of Compliance 13512
Issued July 25, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13512
- Date
- July 25, 2012
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Type II 5 Alpha-reductase Inhibitor
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-FINASTERIDE | 02389878 | Marketed |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB